EUVIMEDEUVIMED entdecken
Crossref

Artificial intelligence in hematopoietic stem cell research and associated malignancies: From disease modeling to cell manufacturing

Heba Adel Abd El Ghaffar, Aya Mohamed Adel Arafat, Eman Hazem AbdelTawab Khattab, Mustafa Ashraf Khattab, Ahmed M Khallaf, Shirihan Mahmoud Anwar Mahgoub

World Journal of Stem Cells · 26.08.2026 · 18 (8)

DOI: 10.4252/wjsc.121077 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Stem Cells, online erschienen am 26.08.2026. Verfasst von Heba Adel Abd El Ghaffar und 5 weiteren Autor:innen. Die Arbeit nennt 119 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hematopoietic stem cells (HSCs) occupy the apex of the blood cell hierarchy, and artificial intelligence (AI) is fundamentally reshaping how their biology is decoded from normal self-renewal to malignant transformation and clinical transplantation. Trajectory inference algorithms applied to single-cell multi-omics have resolved continuous HSC differentiation with lineage priming detectable at the single-cell level, while convolutional neural networks trained on chromatin imaging predict HSC biological age and detect epigenetic rejuvenation signatures. In leukemic stem cell (LSC) biology, multi-omics deep learning models map treatment-resistant quiescent LSC subclones, detect minimal residual disease with an area under the curve of 0.97 and predict venetoclax sensitivity in LSC-enriched niches. Deep learning also maps myeloma stem cell niche interactions and spatial heterogeneity in bone marrow biopsies. Virtual screening powered by AI speeds up LSC-targeted drug discovery, and reinforcement learning and digital twin models improve ex vivo HSC manufacturing and industrial-scale production of chimeric antigen receptor-T cells. In transplantation, natural language processing extraction and hybrid models classify risk for graft-vs -host disease into clinically relevant subgroups. Overall, top-performing AI models serve as computational surrogates for stemness biology but challenges in dataset diversity, interpretability and regulatory compliance need to be addressed before being used in a clinical setting.

Zitieren

APA

Ghaffar, H. A. A. E., Arafat, A. M. A., Khattab, E. H. A., Khattab, M. A., Khallaf, A. M., & Mahgoub, S. M. A. (2026). Artificial intelligence in hematopoietic stem cell research and associated malignancies: From disease modeling to cell manufacturing. World Journal of Stem Cells, 18(8). https://doi.org/10.4252/wjsc.121077

Vancouver

Ghaffar HAAE, Arafat AMA, Khattab EHA, Khattab MA, Khallaf AM, Mahgoub SMA. Artificial intelligence in hematopoietic stem cell research and associated malignancies: From disease modeling to cell manufacturing. World Journal of Stem Cells. 2026;18(8). doi:10.4252/wjsc.121077

BibTeX
@article{Ghaffar2026,
  author = {Ghaffar, Heba Adel Abd El and Arafat, Aya Mohamed Adel and Khattab, Eman Hazem AbdelTawab and Khattab, Mustafa Ashraf and Khallaf, Ahmed M and Mahgoub, Shirihan Mahmoud Anwar},
  title = {Artificial intelligence in hematopoietic stem cell research and associated malignancies: From disease modeling to cell manufacturing},
  journal = {World Journal of Stem Cells},
  year = {2026},
  volume = {18},
  number = {8},
  doi = {10.4252/wjsc.121077}
}
Kostenlos starten →